Comparative efficacy and safety of antiepileptic drugs for the treatment of status epilepticus

Journal of Pharmacy Practice

Volumn 20, Issue 2, 2007, Pages 137-146

  Chung, Steve S ^a   Wang, Norman C ^a   Treiman, David M ^a  

^a BARROW NEUROLOGICAL INSTITUTE   (United States)

Author keywords

Anticonvulsants; Seizures; Status epilepticus

Indexed keywords

ANTICONVULSIVE AGENT; DESMOFLURANE; DIAZEPAM; ETIRACETAM; FOSPHENYTOIN SODIUM; HALOTHANE; ISOFLURANE; KETAMINE; LIDOCAINE; LORAZEPAM; MIDAZOLAM; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NIMODIPINE; PARALDEHYDE; PENTOBARBITAL; PHENOBARBITAL; PHENYTOIN; PROPOFOL; THIOPENTAL; UNCLASSIFIED DRUG; VALPROIC ACID; VERAPAMIL;

ANAPHYLAXIS; ANTICONVULSANT THERAPY; BEHAVIORAL IRRITABILITY; CLINICAL PROTOCOL; COMPARATIVE STUDY; DRUG EFFICACY; DRUG SAFETY; EPILEPTIC STATE; HEART ARRHYTHMIA; HUMAN; HYPOTENSION; HYPOVENTILATION; NONHUMAN; PANCREATITIS; POSITIONAL DIZZINESS; RESPIRATION DEPRESSION; RESPIRATORY DISTRESS; REVIEW; SEDATION; SEIZURE; SIDE EFFECT; SOMNOLENCE; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

EID: 34548134513     PISSN: 08971900     EISSN: 15311937     Source Type: Journal    
DOI: 10.1177/0897190007305134     Document Type: Review

References (91)

1. DeLorenzo RJ, Hauser WA, Towne AR, et al. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology. 1996 ; 46: 1029-1035.
2. Hesdorffer DC, Logroscino G., Cascino G., Annegers JF, Hauser WA Incidence of status epilepticus in Rochester, Minnesota, 1965-1984. Neurology. 1998 ; 50: 735-741.
3. Fountain NB Status epilepticus: risk factors and complications. Epilepsia. 2000 ; 41 (suppl 2). S23 - S30.
4. Theodore WH, Porter RJ, Albert P., et al. The secondarily generalized tonic-clonic seizure: a videotape analysis. Neurology. 1994 ; 44: 1403-1407.
5. Rossetti AO, Hurwitz S., Logroscino G., Bromfield EB Prognosis of status epilepticus: role of aetiology, age, and consciousness impairment at presentation. J Neurol Neurosurg Psychiatry. 2006 ; 77: 611-615.
6. Epilepsy Foundation of America's Working Group on Status Epilepticus. Treatment of convulsive status epilepticus. Recommendations of the Epilepsy Foundation of America's Working Group on Status Epilepticus. JAMA. 1993 ; 270: 854-859.
7. Lothman E. The biochemical basis and pathophysiology of status epilepticus. Neurology. 1990 ; 40: 13-23.
8. Nevander G., Ingvar M., Auer R., Siesjo BK Status epilepticus in well-oxygenated rats causes neuronal necrosis. Ann Neurol. 1985 ; 18: 281-290.
9. Alldredge BK, Lowenstein DH Status epilepticus: new concepts. Curr Opin Neurol. 1999 ; 12: 183-190.
10. Lowenstein DH, Bleck T., Macdonald RL It's time to revise the definition of status epilepticus. Epilepsia. 1999 ; 40: 120-122.
11. DeLorenzo RJ Status epilepticus: concepts in diagnosis and treatment. Semin Neurol. 1990 ; 10: 396-405.
12. Treiman DM Electroclinical features of status epilepticus. J Clin Neurophysiol. 1995 ; 12: 343-362.
13. Treiman DM, Walton NY, Kendrick C. A progressive sequence of electroencephalographic changes during generalized convulsive status epilepticus. Epilepsy Res. 1990 ; 5: 49-60.
14. Treiman DM Status epilepticus. Baillieres Clin Neurol. 1996 ; 5: 821-839.
15. Bleck TP Advances in the management of refractory status epilepticus. Crit Care Med. 1993 ; 21: 955-957.
16. Jagoda A., Riggio S. Refractory status epilepticus in adults. Ann Emerg Med. 1993 ; 22: 1337-1348.
17. Treiman DM, Meyers PD, Walton NY, et al. A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med. 1998 ; 339: 792-798.
18. Alldredge BK, Gelb AM, Isaacs SM, et al. A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med. 2001 ; 345: 631-637.
19. Lowenstein DH, Alldredge BK, Allen F., et al. The prehospital treatment of status epilepticus (PHTSE) study: design and methodology. Control Clin Trials. 2001 ; 22: 290-309.
20. Bleck TP Management approaches to prolonged seizures and status epilepticus. Epilepsia. 1999 ; 40 (suppl 1). S59 - S63.
21. Treiman DM General principles of treatment: responsive and intractable status epilepticus in adults. Adv Neurol. 1983 ; 34: 377-384.
22. Treiman DM Therapy of status epilepticus in adults and children. Curr Opin Neurol. 2001 ; 14: 203-210.
23. Lowenstein DH, Alldredge BK Status epilepticus at an urban public hospital in the 1980s. Neurology. 1993 ; 43: 483-488.
24. DeLorenzo RJ, Waterhouse EJ, Towne AR, et al. Persistent nonconvulsive status epilepticus after the control of convulsive status epilepticus. Epilepsia. 1998 ; 39: 833-840.
25. Cock HR, Schapira AH A comparison of lorazepam and diazepam as initial therapy in convulsive status epilepticus. QJM. 2002 ; 95: 225-231.
26. Treiman DM Pharmacokinetics and clinical use of benzodiazepines in the management of status epilepticus. Epilepsia. 1989 ; 30 (suppl 2). S4 - S10.
27. Cook M. Treatment of epilepsy. Aust Fam Physician. 1995 ; 24: 1261-1269.
28. Bleck TP Refractory status epilepticus in 2001. Arch Neurol. 2002 ; 59: 188-189.
29. O'Brien TJ, Cascino GD, So EL, Hanna DR Incidence and clinical consequence of the purple glove syndrome in patients receiving intravenous phenytoin. Neurology. 1998 ; 51: 1034-1039.
30. Ramsay RE, DeToledo J. Intravenous administration of fosphenytoin: options for the management of seizures. Neurology. 1996 ; 46: S17 - S19.
31. DeToledo JC, Ramsay RE Fosphenytoin and phenytoin in patients with status epilepticus: improved tolerability versus increased costs. Drug Saf. 2000 ; 22: 459-466.
32. Graves N. Pharmacoeconomic considerations in treatment options for acute seizures. J Child Neurol. 1998 ; 13 (suppl 1). S27 - S29.
33. Ramsay RE, Wilder BJ, Uthman BM, et al. Intramuscular fosphenytoin (Cerebyx) in patients requiring a loading dose of phenytoin. Epilepsy Res. 1997 ; 28: 181-187.
34. Devinsky O., Leppik I., Willmore LJ, et al. Safety of intravenous valproate. Ann Neurol. 1995 ; 38: 670-674.
35. Hodges BM, Mazur JE Intravenous valproate in status epilepticus. Ann Pharmacother. 2001 ; 35: 1465-1470.
36. Hovinga CA, Chicella MF, Rose DF, Eades SK, Dalton JT, Phelps SJ Use of intravenous valproate in three pediatric patients with nonconvulsive or convulsive status epilepticus. Ann Pharmacother. 1999 ; 33: 579-584.
37. Kaplan PW Intravenous valproate treatment of generalized nonconvulsive status epilepticus. Clin Electroencephalogr. 1999 ; 30: 1-4.
38. Sheth RD, Gidal BE Intravenous valproic acid for myoclonic status epilepticus. Neurology. 2000 ; 54: 1201.
39. Giroud M., Dumas R. Treatment of status epilepticus by sodium valproate. Neurophysiol Clin. 1988 ; 18: 21-32.
40. Sinha S., Naritoku DK Intravenous valproate is well tolerated in unstable patients with status epilepticus. Neurology. 2000 ; 55: 722-724.
41. Wheless JW, Vazquez BR, Kanner AM, Ramsay RE, Morton L., Pellock JM Rapid infusion with valproate sodium is well tolerated in patients with epilepsy. Neurology. 2004 ; 63: 1507-1508.
42. Uberall MA, Trollmann R., Wunsiedler U., Wenzel D. Intravenous valproate in pediatric epilepsy patients with refractory status epilepticus. Neurology. 2000 ; 54: 2188-2189.
43. Venkataraman V., Wheless JW Safety of rapid intravenous infusion of valproate loading doses in epilepsy patients. Epilepsy Res. 1999 ; 35: 147-153.
44. Yu KT, Mills S., Thompson N., Cunanan C. Safety and efficacy of intravenous valproate in pediatric status epilepticus and acute repetitive seizures. Epilepsia. 2003 ; 44: 724-726.
45. Kumar A., Bleck TP Intravenous midazolam for the treatment of refractory status epilepticus. Crit Care Med. 1992 ; 20: 483-438.
46. Prasad A., Worrall BB, Bertram EH, Bleck TP Propofol and midazolam in the treatment of refractory status epilepticus. Epilepsia. 2001 ; 42: 380-386.
47. Claassen J., Hirsch LJ, Emerson RG, Bates JE, Thompson TB, Mayer SA Continuous EEG monitoring and midazolam infusion for refractory nonconvulsive status epilepticus. Neurology. 2001 ; 57: 1036-1042.
48. Mayhue FE IM midazolam for status epilepticus in the emergency department. Ann Emerg Med. 1988 ; 17: 643-645.
49. Wolfe TR, Macfarlane TC Intranasal midazolam therapy for pediatric status epilepticus. Am J Emerg Med. 2006 ; 24: 343-346.
50. LeDuc TJ, Goellner WE, el Sanadi N. Out-of-hospital midazolam for status epilepticus. Ann Emerg Med. 1996 ; 28: 377.
51. Holmes GL, Riviello JJ Jr. Midazolam and pentobarbital for refractory status epilepticus. Pediatr Neurol. 1999 ; 20: 259-264.
52. Rashkin MC, Youngs C., Penovich P. Pentobarbital treatment of refractory status epilepticus. Neurology. 1987 ; 37: 500-503.
53. Lowenstein DH, Alldredge BK Status epilepticus. N Engl J Med. 1998 ; 338: 970-976.
54. Goldberg MA, McIntyre HB Barbiturates in the treatment of status epilepticus. Adv Neurol. 1983 ; 34: 499-503.
55. Vining EP Use of barbiturates and benzodiazepines in treatment of epilepsy. Neurol Clin. 1986 ; 4: 617-632.
56. Osorio I., Reed RC Treatment of refractory generalized tonicclonic status epilepticus with pentobarbital anesthesia after high-dose phenytoin. Epilepsia. 1989 ; 30: 464-471.
57. Yaffe K., Lowenstein DH Prognostic factors of pentobarbital therapy for refractory generalized status epilepticus. Neurology. 1993 ; 43: 895-900.
58. Van Ness PC Pentobarbital and EEG burst suppression in treatment of status epilepticus refractory to benzodiazepines and phenytoin. Epilepsia. 1990 ; 31: 61-67.
59. Lowenstein DH, Aminoff MJ, Simon RP Barbiturate anesthesia in the treatment of status epilepticus: clinical experience with 14 patients. Neurology. 1988 ; 38: 395-400.
60. Krishnamurthy KB, Drislane FW Depth of EEG suppression and outcome in barbiturate anesthetic treatment for refractory status epilepticus. Epilepsia. 1999 ; 40: 759-762.
61. O'Brien MD Management of major status epilepticus in adults. BMJ. 1990 ; 301: 918.
62. Parviainen I., Uusaro A., Kalviainen R., Kaukanen E., Mervaala E., Ruokonen E. High-dose thiopental in the treatment of refractory status epilepticus in intensive care unit. Neurology. 2002 ; 59: 1249-1251.
63. Lohr A. Jr, Werneck LC Comparative non-randomized study with midazolam versus thiopental in children with refractory status epilepticus. Arq Neuropsiquiatr. 2000 ; 58: 282-287.
64. Ghosh IR, Langford RM, Nieminen K., Kari A., Takala J. Repetitive synchronized cyclical oscillations of multisystem parameters subsequent to high-dose thiopental therapy for status epilepticus secondary to herpes encephalitis. Br J Anaesth. 2000 ; 85: 471-473.
65. Nadal P., Nicolas JM, Font C., Vilella A., Nogue S. Pneumonia in ventilated head trauma patients: the role of thiopental therapy. Eur J Emerg Med. 1995 ; 2: 14-16.
66. Begemann M., Rowan AJ, Tuhrim S. Treatment of refractory complex-partial status epilepticus with propofol: case report. Epilepsia. 2000 ; 41: 105-109.
67. Campostrini R., Bati MB, Giorgi C., et al. Propofol in the treatment of convulsive status epilepticus: a report of four cases. Riv Neurol. 1991 ; 61: 176-179.
68. Harrison AM, Lugo RA, Schunk JE Treatment of convulsive status epilepticus with propofol: case report. Pediatr Emerg Care. 1997 ; 13: 420-422.
69. Rossetti AO, Reichhart MD, Schaller MD, Despland PA, Bogousslavsky J. Propofol treatment of refractory status epilepticus: a study of 31 episodes. Epilepsia. 2004 ; 45: 757-763.
70. Stecker MM, Kramer TH, Raps EC, O'Meeghan R., Dulaney E., Skaar DJ Treatment of refractory status epilepticus with propofol: clinical and pharmacokinetic findings. Epilepsia. 1998 ; 39: 18-26.
71. Brown LA, Levin GM Role of propofol in refractory status epilepticus. Ann Pharmacother. 1998 ; 32: 1053-1059.
72. Finley GA, MacManus B., Sampson SE, Fernandez CV, Retallick R. Delayed seizures following sedation with propofol. Can J Anaesth. 1993 ; 40: 863-865.
73. Bray RJ Propofol-infusion syndrome in children. Lancet. 1999 ; 353: 2074-2075.
74. Claassen J., Hirsch LJ, Emerson RG, Mayer SA Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review. Epilepsia. 2002 ; 43: 146-153.
75. Parke TJ, Stevens JE, Rice AS, et al. Metabolic acidosis and fatal myocardial failure after propofol infusion in children: five case reports. BMJ. 1992 ; 305: 613-616.
76. Perry MS, Holt PJ, Sladky JT Topiramate loading for refractory status epilepticus in children. Epilepsia. 2006 ; 47: 1070-1071.
77. Blumkin L., Lerman-Sagie T., Houri T., et al. Pediatric refractory partial status epilepticus responsive to topiramate. J Child Neurol. 2005 ; 20: 239-241.
78. Tarulli A., Drislane FW The use of topiramate in refractory status epilepticus. Neurology. 2004 ; 62: 837.
79. Bensalem MK, Fakhoury TA Topiramate and status epilepticus: report of three cases. Epilepsy Behav. 2003 ; 4: 757-760.
80. Kahriman M., Minecan D., Kutluay E., Selwa L., Beydoun A. Efficacy of topiramate in children with refractory status epilepticus. Epilepsia. 2003 ; 44: 1353-1356.
81. Rupprecht S., Franke K., Fitzek S., Witte OW, Hagemann G. Levetiracetam as a treatment option in non-convulsive status epilepticus. Epilepsy Res. 2007 ; 73: 238-244.
82. Rossetti AO, Bromfield EB Determinants of success in the use of oral levetiracetam in status epilepticus. Epilepsy Behav. 2006 ; 8: 651-654.
83. Patel NC, Landan IR, Levin J., Szaflarski J., Wilner AN The use of levetiracetam in refractory status epilepticus. Seizure. 2006 ; 15: 137-141.
84. Rossetti AO, Bromfield EB Levetiracetam in the treatment of status epilepticus in adults: a study of 13 episodes. Eur Neurol. 2005 ; 54: 34-38.
85. Fujikawa DG Neuroprotective effect of ketamine administered after status epilepticus onset. Epilepsia. 1995 ; 36: 186-195.
86. Sheth RD, Gidal BE Refractory status epilepticus: response to ketamine. Neurology. 1998 ; 51: 1765-1766.
87. Borris DJ, Bertram EH, Kapur J. Ketamine controls prolonged status epilepticus. Epilepsy Res. 2000 ; 42: 117-122.
88. George B., Kulkarni SK, Mathur R. Motor and electrographic response of refractory experimental status epilepticus in rats and effect of calcium channel blockers. Indian J Exp Biol. 2000 ; 38: 105-112.
89. Iannetti P., Spalice A., Parisi P. Calcium-channel blocker verapamil administration in prolonged and refractory status epilepticus. Epilepsia. 2005 ; 46: 967-969.
90. Rossetti AO, Logroscino G., Bromfield EB Refractory status epilepticus: effect of treatment aggressiveness on prognosis. Arch Neurol. 2005 ; 62: 1698-1702.
91. Manno EM New management strategies in the treatment of status epilepticus. Mayo Clin Proc. 2003 ; 78: 508-518.